126 related articles for article (PubMed ID: 37863326)
1. Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway.
Xiang S; Jian L; Zeng H; Wu H; Ge B; Zhang P; Lin J; Guo A; Zhou B
Biochem Pharmacol; 2023 Dec; 218():115859. PubMed ID: 37863326
[TBL] [Abstract][Full Text] [Related]
2. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
3. Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma.
Vardabasso C; Gaspar-Maia A; Hasson D; Pünzeler S; Valle-Garcia D; Straub T; Keilhauer EC; Strub T; Dong J; Panda T; Chung CY; Yao JL; Singh R; Segura MF; Fontanals-Cirera B; Verma A; Mann M; Hernando E; Hake SB; Bernstein E
Mol Cell; 2015 Jul; 59(1):75-88. PubMed ID: 26051178
[TBL] [Abstract][Full Text] [Related]
4. H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation.
Jostes S; Vardabasso C; Dong J; Carcamo S; Singh R; Phelps R; Meadows A; Grossi E; Hasson D; Bernstein E
Genes Dev; 2024 May; 38(7-8):336-353. PubMed ID: 38744503
[TBL] [Abstract][Full Text] [Related]
5. The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study.
Xiang S; Zeng H; Xia F; Ji Q; Xue J; Ren R; Que F; Zhou B
Life Sci; 2021 Jan; 264():118598. PubMed ID: 33189818
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling.
Chen XY; Li DF; Han JC; Wang B; Dong ZP; Yu LN; Pan ZH; Qu CJ; Chen Y; Sun SG; Zheng QS
Oncotarget; 2017 May; 8(21):34565-34575. PubMed ID: 28410220
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin inhibits non-small cell lung cancer progression via m
Cui Y; Wu Y; Wang C; Wang Z; Li Y; Jiang Z; Zhao W; Pan Z
Phytomedicine; 2022 Sep; 104():154299. PubMed ID: 35816995
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells.
Wang Y; Ma J; Yan X; Chen X; Si L; Liu Y; Han J; Hao W; Zheng Q
Recent Pat Anticancer Drug Discov; 2016; 11(2):215-27. PubMed ID: 26951491
[TBL] [Abstract][Full Text] [Related]
9. H2A.Z chaperones converge on histone H4 acetylation for melanoma cell proliferation.
Jostes S; Vardabasso C; Dong J; Carcamo S; Singh R; Phelps R; Meadows A; Hasson D; Bernstein E
bioRxiv; 2023 Nov; ():. PubMed ID: 38076914
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice.
Wu CH; Chen HY; Wang CW; Shieh TM; Huang TC; Lin LC; Wang KL; Hsia SM
Oncotarget; 2016 Nov; 7(45):73432-73447. PubMed ID: 27708238
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.
Yang HD; Kim PJ; Eun JW; Shen Q; Kim HS; Shin WC; Ahn YM; Park WS; Lee JY; Nam SW
Oncotarget; 2016 Mar; 7(10):11412-23. PubMed ID: 26863632
[TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway.
Huang Y; Liu C; Zeng WC; Xu GY; Wu JM; Li ZW; Huang XY; Lin RJ; Shi X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840737
[TBL] [Abstract][Full Text] [Related]
14. Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq.
Chen X; Yang M; Hao W; Han J; Ma J; Wang C; Sun S; Zheng Q
Gene; 2016 Oct; 592(1):86-98. PubMed ID: 27461947
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell.
Chen T; Deng S; Lin R
BMC Pharmacol Toxicol; 2017 Jul; 18(1):57. PubMed ID: 28716056
[TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin regulates the circ_0002860/miR-431-5p/RAB9A axis to function as a tumor inhibitor in melanoma.
Wu S; Wang J
J Venom Anim Toxins Incl Trop Dis; 2023; 29():e20220019. PubMed ID: 37020694
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.
Li C; Zhou X; Sun C; Liu X; Shi X; Wu S
Oncol Rep; 2019 Apr; 41(4):2502-2510. PubMed ID: 30720124
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin Induces Mitochondrial Dysfunction and Apoptosis by Inhibiting mitoNEET in a Reactive Oxygen Species-Dependent Manner in A375 Human Melanoma Cells.
Chen XY; Ren HH; Wang D; Chen Y; Qu CJ; Pan ZH; Liu XN; Hao WJ; Xu WJ; Wang KJ; Li DF; Zheng QS
Oxid Med Cell Longev; 2019; 2019():9817576. PubMed ID: 30805086
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy.
Zhang Z; Chen WQ; Zhang SQ; Bai JX; Liu B; Yung KK; Ko JK
Phytomedicine; 2022 Nov; 106():154406. PubMed ID: 36029643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
